Berlin, Germany
Berlin, Germany

Time filter

Source Type

A method of depositing at least one substance on a target substrate (1) comprises the step of operating at least one droplet dispenser (21) such that droplets (2) including the at least one substance are deposited on the target substrate (1), wherein the target substrate (1) has a substrate surface including spatially delimited receptacle sections (3) being arranged for accommodating the droplets (2), and the at least one droplet dispenser (21) is controlled in dependency on the locations of the receptacle sections (3) such that the droplets (2) are directed onto the receptacle sections (3). Furthermore, a dispenser device (100) for depositing at least one substance on a target substrate (1) is described.


LFA (Lateral Flow Assay) market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.  The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players. The Players mentioned in our report  GE healthcare  Merck Millipore  Sartorius  Pall  Kestrel Bio  Abingdon Health  BioDot, Inc  IMMY  Skannex  DCN  Qiagen  Senova  Scienion  ANP Technology, Inc  BBI Solutions  Cytodiagnostics Chapter 1 About the LFA (Lateral Flow Assay) Industry      1.1 Industry Definition        1.1.1 Types of LFA (Lateral Flow Assay) industry            1.1.1.1 Pregnancy            1.1.1.2 Drugs            1.1.1.3 Swine flue            1.1.1.4 HIV            1.1.1.5 Others      1.2 Main Market Activities      1.3 Similar Industries      1.4 Industry at a Glance Chapter 2 World Market Competition Landscape      2.1 LFA (Lateral Flow Assay) Markets by Regions        2.1.1 USA  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.2 Europe  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.3 China  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.4 India  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.5 Japan  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.6 South East Asia  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015      2.2 World LFA (Lateral Flow Assay) Market by Types  Pregnancy  Drugs  Swine flue  HIV  Others      2.3 World LFA (Lateral Flow Assay) Market by Applications      2.4 World LFA (Lateral Flow Assay) Market Analysis        2.4.1 World LFA (Lateral Flow Assay) Market Revenue and Growth Rate 2011-2016        2.4.2 World LFA (Lateral Flow Assay) Market Consumption and Growth rate 2011-2016        2.4.3 World LFA (Lateral Flow Assay) Market Price Analysis 2011-2016 Chapter 3 World LFA (Lateral Flow Assay) Market share      3.1 Major Production Market share by Players      3.2 Major Revenue (M USD) Market share by Players      3.3 Major Production Market share by Regions in 2015, Through 2021      3.4 Major Revenue (M USD) Market share By Regions in 2015, Through 2021 For more information, please visit http://www.wiseguyreports.com


A method of electron microscopy imaging of samples, using an electron microscope (100) having a microscope column (10) and a transfer device (11) with a grid carriage (12), comprises the steps of preparing multiple samples (1) on a single electron microscopy grid (2), including dispensing the samples (1) with a dispenser device (30) on distinct positions on the grid (2), introducing the grid (1) with the transfer device (11) into the microscope column (10), and electron microscopy imaging of the samples (1), wherein the preparing step includes holding the grid (2) on the grid carriage (12) of the transfer device (11) or on a grid holder device (20) provided at the electron microscope (100) and dispensing the samples (1) on the grid (2) while holding it on the grid carriage (12) or on the grid holder device (20). Furthermore, an electron microscope (100) for electron microscopy imaging of samples is described.


A method of depositing at least one substance on a target substrate (1) comprises the step of operating at least one droplet dispenser (21) such that droplets (2) including the at least one substance are deposited on the target substrate (1), wherein the target substrate (1) has a substrate surface including spatially delimited receptacle sections (3) being arranged for accommodating the droplets (2), and the at least one droplet dispenser (21) is controlled in dependency on the locations of the receptacle sections (3) such that the droplets (2) are directed onto the receptacle sections (3). Furthermore, a dispenser device (100) for depositing at least one substance on a target substrate (1) is described.


A method of electron microscopy imaging of samples, using an electron microscope (100) having a microscope column (10) and a transfer device (11) with a grid carriage (12), comprises the steps of preparing multiple samples (1) on a single electron microscopy grid (2), including dispensing the samples (1) with a dispenser device (30) on distinct positions on the grid (2), introducing the grid (1) with the transfer device (11) into the microscope column (10), and electron microscopy imaging of the samples (1), wherein the preparing step includes holding the grid (2) on the grid carriage (12) of the transfer device (11) or on a grid holder device (20) provided at the electron microscope (100) and dispensing the samples (1) on the grid (2) while holding it on the grid carriage (12) or on the grid holder device (20). Furthermore, an electron microscope (100) for electron microscopy imaging of samples is described.


Grant
Agency: European Commission | Branch: FP7 | Program: CP-FP | Phase: KBBE.2010.3.2-04 | Award Amount: 3.89M | Year: 2011

Monitoring the quality of drinking water is of paramount importance for public health. Water is not a commercial product but a heritage that must be protected, defended and treated as such (Water Framework Directive 2000/60/EC). The threat of waterborne diseases in Europe will predictably increase in the future as the human population increases and as a result of globalization and migration from non-EU countries and of climate change. Development of efficient, sensitive, robust, rapid and inexpensive tests to monitor various aspects of water quality represents an essential milestone within the strategy for control and prevention of diseases caused by waterborne pathogens and by algal toxins. Traditional methods for the detection of waterborne pathogens, based on cultivation, biochemical characterisation and microscopic detection are laborious and time-consuming; molecular biological tools have now greatly enhanced our ability to investigate biodiversity by identifying species and to estimate gene flow and distribution of species in time and space. AQUA aims to design and develop a universal microarray chip for the high-throughput detection in water of known and emerging pathogens (bacteria, viruses, protozoa and cyanobacteria) and to assess the water quality monitoring the presence of select bioindicators (i.e. diatoms). A chip able to detect cyanobacterial toxins will also be developed. These innovative molecular tools should be amenable to automation so that they could be deployed on moorings for routine semi-continuous monitoring of water quality. AQUA also aims to identify cyanophages potentially capable of controlling and mitigating the periodical blooming of toxic cyanobacteria in drinking water reservoirs. Overall, these innovative and cost efficient technologies will reduce energy requirements and improve performance of water treatment, and allow rapid management response to new situations brought about by environmental (including climatic) changes.


Patent
Greiner Bio One GmbH and Scienion | Date: 2013-09-11

The present invention relates to a process for the production of a reaction chamber assembly, wherein a flat substrate (10) and bottomless reaction chambers (20) are provided, the substrate (10) is first loaded with a biological agent and then the bottomless reaction chambers (20) are bonded glue-free to the substrate (10), in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate (10) suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber (20), wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber (20) to the substrate (10).


Patent
Greiner Bio One GmbH and Scienion | Date: 2013-09-11

The present invention relates to a process for the production of a reaction chamber assembly, wherein a flat substrate and bottomless reaction chambers are provided, the substrate is first loaded with a biological agent and then the bottomless reaction chambers are bonded glue-free to the substrate, in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber, wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber to the substrate.


Patent
Scienion and Greiner Bio One Gmbh | Date: 2013-03-06

A process for the production of a reaction chamber assembly, wherein a flat substrate and bottomless reaction chambers are provided, the substrate is first loaded with a biological agent and then the bottomless reaction chambers are bonded glue-free to the substrate, in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber, wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber to the substrate.


Patent
Scienion | Date: 2012-08-22

The invention relates to a microdispenser (1) for dispensing a liquid sample in a dispensing device, with a sample container (2) for receiving the liquid sample, and with a nozzle (7) for dispensing the sample located in the sample container (2). The microdispenser (1) with the filled sample container (2) can in this case be stored independently of and fluidically separately from the dispensing device, without the sample escaping from the sample container (2) during storage.

Loading Scienion collaborators
Loading Scienion collaborators